EU Seeks Views on Sanofi's Concessions to End Competition Probe

By Edith Hancock

The European Commission is seeking feedback on a package of concessions healthcare group Sanofi offered to end a competition investigation into the company.

It comes after the European Union's executive arm started investigating Sanofi in June over concerns it unfairly pursued a campaign to disparage a rival flu vaccine by portraying it as inferior to its own Efluelda.

The commission said that Sanofi offered to publish statements on its French and German websites acknowledging assessments of the vaccines carried out by the European Centre for Disease Prevention and Control and national immunisation technical advisory groups, and to avoid portraying rival CSL Seqirus's drug Fluad negatively, or claiming that Efluelda is safer or more effective.

The regulator set an Aug. 21 deadline to receive feedback on the offer.

Write to Edith Hancock at [e-mail]

(END) Dow Jones Newswires

07-08-26 0611ET